To evaluate the efficacy and safety of intravenous bolus versus intravenous infusion of iron sucrose in pregnant women with severe iron deficiency anemia

Authors

  • Urvashi Verma Department of Obstetrics and Gynecology, S. N. Medical College, Agra, Uttar Pradesh, India
  • Saroj Singh Department of Obstetrics and Gynecology, S. N. Medical College, Agra, Uttar Pradesh, India
  • Shikha Singh Department of Obstetrics and Gynecology, S. N. Medical College, Agra, Uttar Pradesh, India
  • Anu Pathak Department of Obstetrics and Gynecology, S. N. Medical College, Agra, Uttar Pradesh, India
  • Poonam Yadav Department of Obstetrics and Gynecology, S. N. Medical College, Agra, Uttar Pradesh, India
  • . Benazeer Department of Obstetrics and Gynecology, S. N. Medical College, Agra, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20172323

Keywords:

Hemoglobin, I/V Bolus, Iron deficiency anemia, Iron sucrose

Abstract

Background: Objective of present study was to evaluate the efficacy and safety of intravenous bolus iron sucrose for iron deficiency anemia during pregnancy during second and third trimester women presenting at S.N. medical college, Agra.

Methods: It was a prospective controlled trial and study was carried out in Department of Obstetrics and Gynecology, S.N. medical college, Agra in the year 2014-2016. 100Pregnant women with proved iron deficiency anemia having hemoglobin between 4-9gm/dl was included in this study. Total Iron deficit was calculated by standard formula. Target haemoglobin was 11gm/dl. Iron sucrose was administered by intravenous bolus and intravenous infusion techniques. Hemoglobin was repeated at 2 weeks, 4 weeks and 8 weeks after the last dose of intravenous iron sucrose

Results: In Group A (bolus group n=50) 22 women had gestational age >24-28weeks and 20 women gestational age >18-24 weeks, with Mean gestational age of 24.36±3.78 weeks. In Group B (infusion group n=50) most of the patients 24 (48%) had gestational age >24-28 weeks, 18 (36%) had gestational age >18-24 weeks, with Mean gestational age of 24.94±3.51 weeks. Target hemoglobin was achieved in group A in all 50 (100%) cases and in group B in 49 (98%) cases. There were no allergic reactions.

Conclusions: This study showed a significant improvement in the hemoglobin of the patients after receiving intravenous bolus and intravenous infusion of iron sucrose. Patients achieved the target hemoglobin of 11gm/dl. Both therapies are safe, effective and faster acting for the treatment of iron deficiency anaemia during pregnancy. The bolus push technique is more convenient to women and care provider, less time consuming as well as cost effective.

References

World Health Organization, author. Prevention and Management of Severe Anaemia in Pregnancy: report of a technical working group. Geneva: 1994. WHL/FHE/MSM/93.3.

Idowu OA, Mafiena CF, Sotiloye D. Anemia in pregnancy: Asurvey of pregnant women in Abeukuta Niegeria. African Health Sience. 2005;5(4):295-9.

Allen LH. Pregnancy and iron deficiency: unresolved issues. Nut Rev. 1997;55:91-101.

Breymann C. Iron deficiency and anemia in pregnancy: modern aspects of diagnosis and treatment. Blood Cells Mol Dis. 2002;29:506-16.

WHO data presented at FIGO meeting in 2003 in Chile. Semin Hematol. 2006;43(Supple 6):528-31.

Perewusny KG, Huck R, Huck A, Breymann C. Parenteral iron sucrose complex. Br J Nutr. 2002;88:3-10.

Al- Momen A K, Al- Meshari A, Al-Nuaim L, Saddique A, Abutalin Z, Khashogi T, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;69:121-4.

Bayoumeu F, Subiran-Busset C, Baka NE, Legagneur H, Monnier-Barbarino P, Laxenaire M C. Iron therapy in iron deficiency anemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol. 2002;186:518-22.

Wali A, Mushtaq A, Nilofer. Comparative study- efficacy, Safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnany. J Pak Med Assoc. 2002;52(9):392-5.

Harrison KA. Maternal mortality and anaemia in pregnancy. W Afr Med J. 1975;23:27-31.

Yaqoob N, Abbasi SM. Nutritional iron deficiency in our population. J Coll Physicians Surg Pak. 2002;12:395-7.

Breymann C. Anemia working group. Current aspects of diagnosis and therapy of iron deficiency anemia in pregnancy. Schweiz Rundsch Med Prax. 2001;90:1283-91.

Macdougall IC, Roche A. Administration of intravenous iron sucrose as a 2-minute push to CKD women: a prospective evaluation of 2,297 injections. Am kidney Dis. 2005;46(2):283-9.

Diwaker H, Gautham MS, Maryonda IT, Rapid verses slow i/v iron sucrose administration in an Indian rural pregnant population with iron deficiency anemia. J Perinatal Neonatal Care. 2011;12(2):45- 7.

Downloads

Published

2017-05-25

Issue

Section

Original Research Articles